<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-pharmaceuticals-10-00084">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zeb</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hameed</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Dalvandi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Iqbal Choudhary</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Basha</surname>
    <given-names>F.Z.</given-names>
   </name>
  </person-group>
  <article-title>Quinoxaline derivatives: Novel and selective butyrylcholinesterase inhibitors</article-title>
  <source>Med. Chem.</source>
  <year>2014</year>
  <volume>10</volume>
  <fpage>724</fpage>
  <lpage>729</lpage>
  <pub-id pub-id-type="doi">10.2174/1573406410666140526145429</pub-id>
  <?supplied-pmid 24875826?>
  <pub-id pub-id-type="pmid">24875826</pub-id>
 </element-citation>
</ref>
